tiprankstipranks
Trending News
More News >
SMS Lifesciences India Ltd. (IN:SMSLIFE)
:SMSLIFE
India Market
Advertisement

SMS Lifesciences India Ltd. (SMSLIFE) Financial Statements

Compare
0 Followers

SMS Lifesciences India Ltd. Financial Overview

SMS Lifesciences India Ltd.'s market cap is currently ₹3.75B. The company's EPS TTM is ₹9.83; its P/E ratio is 18.67; and it has a dividend yield of 0.11%. SMS Lifesciences India Ltd. is scheduled to report earnings on May 29, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 3.45B₹ 3.06B₹ 3.16B₹ 3.47B₹ 2.57B
Gross Profit₹ 505.79M₹ 962.44M₹ 875.57M₹ 875.42M₹ 702.13M
Operating Income₹ 300.42M₹ 359.47M₹ 180.47M₹ 246.54M₹ 223.85M
EBITDA₹ 498.99M₹ 349.41M₹ 341.76M₹ 489.11M₹ 319.58M
Net Income₹ 201.09M₹ 90.93M₹ 114.63M₹ 253.22M₹ 135.57M
Balance Sheet
Cash & Short-Term Investments₹ 15.08M₹ 5.70M₹ 9.54M₹ 33.56M₹ 106.25M
Total Assets₹ 3.90B₹ 3.91B₹ 3.37B₹ 3.57B₹ 3.02B
Total Debt₹ 864.09M₹ 1.01B₹ 869.98M₹ 795.98M₹ 646.86M
Net Debt₹ 849.00M₹ 1.00B₹ 868.47M₹ 786.11M₹ 561.50M
Total Liabilities₹ 1.78B₹ 1.97B₹ 1.73B₹ 1.92B₹ 1.73B
Stockholders' Equity₹ 1.97B₹ 1.77B₹ 1.64B₹ 1.52B₹ 1.29B
Cash Flow
Free Cash Flow₹ 144.61M₹ 34.38M-₹ -623.94M₹ -3.87M
Operating Cash Flow₹ 298.10M₹ 243.06M-₹ -112.41M₹ 351.70M
Investing Cash Flow₹ -150.61M₹ -184.50M-₹ -71.43M₹ -262.35M
Financing Cash Flow₹ -148.15M₹ -65.64M-₹ 108.33M₹ -25.46M
Currency in INR

SMS Lifesciences India Ltd. Earnings and Revenue History

SMS Lifesciences India Ltd. Debt to Assets

SMS Lifesciences India Ltd. Cash Flow

SMS Lifesciences India Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis